BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.55 | -0.16 | 0.00 | 0.00 |
| FCF Yield | -9.51% | -14.77% | -16.08% | -13.55% |
| EV / EBITDA | -11.50 | -8.67 | -8.12 | -7.04 |
| Quality | ||||
| ROIC | -45.35% | -105.46% | -156.94% | -105.39% |
| Gross Margin | 55.35% | 44.45% | 22.17% | 31.87% |
| Cash Conversion Ratio | 0.52 | 0.68 | 0.82 | 0.69 |
| Growth | ||||
| Revenue 3-Year CAGR | 66.08% | 82.00% | 140.35% | 112.84% |
| Free Cash Flow Growth | 4.77% | 4.77% | -24.46% | -108.35% |
| Safety | ||||
| Net Debt / EBITDA | -1.20 | -1.74 | -0.97 | 0.17 |
| Interest Coverage | -3.62 | -5.08 | -7.59 | -10.05 |
| Efficiency | ||||
| Inventory Turnover | 3.08 | 2.85 | 3.11 | 1.54 |
| Cash Conversion Cycle | 23.60 | 63.56 | 74.41 | 121.17 |